(Q41435733)

30 September 2017

title

Elevated serum adenosine deaminase levels in secondary hemophagocytic lymphohistiocytosis (English)

1 reference

30 September 2017

W Chen

1

1 reference

30 September 2017

S Zhang

2

1 reference

30 September 2017

W Zhang

3

1 reference

30 September 2017

X Yang

4

1 reference

30 September 2017

J Xu

5

1 reference

30 September 2017

H Qiu

6

1 reference

30 September 2017

X Zhang

7

1 reference

30 September 2017

J Li

8

1 reference

30 September 2017

publication date

12 March 2015

1 reference

International Journal of Laboratory Hematology

30 September 2017

published in

1 reference

30 September 2017

volume

37

1 reference

30 September 2017

issue

4

1 reference

30 September 2017

page(s)

544-550

1 reference

Hemophagocytic lymphohistiocytosis (HLH) and related disorders

30 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FIJLH.12334

How I treat hemophagocytic lymphohistiocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJLH.12334

HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJLH.12334

Serum neopterin levels as a diagnostic marker of hemophagocytic lymphohistiocytosis syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJLH.12334

The importance of adenosine deaminase for lymphocyte development and function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJLH.12334

The evaluation of lipid peroxidation and adenosine deaminase activity in patients with Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJLH.12334

Serum adenosine deaminase activity as a predictor of disease severity in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJLH.12334

Primary and secondary hemophagocytic lymphohistiocytosis: clinical features, pathogenesis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJLH.12334

The expanding universe of T-cell subsets: Th1, Th2 and more.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJLH.12334

Early diagnostic and prognostic significance of a specific Th1/Th2 cytokine pattern in children with haemophagocytic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJLH.12334

21 January 2018

Hemophagocytic syndromes

1 reference

https://api.crossref.org/works/10.1111%2FIJLH.12334

Serum adenosine deaminase levels in pancreatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJLH.12334

Gene therapy for severe combined immunodeficiency due to adenosine deaminase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJLH.12334

Serum adenosine deaminase activities during acute attacks and attack-free periods of familial Mediterranean fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJLH.12334

Assessment of adenosine deaminase levels in rheumatoid arthritis patients receiving anti-TNF-alpha therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJLH.12334

21 January 2018

Identifiers

DOI

10.1111/IJLH.12334

1 reference

30 September 2017

1 reference